Literature DB >> 9583994

Peptide binding to MHC class I is determined by individual pockets in the binding groove.

T E Johansen1, K McCullough, B Catipovic, X M Su, M Amzel, J P Schneck.   

Abstract

H-2Kb and HLA-A2 are MHC4 class I molecules with a similar overall structure. Important differences between these two class I molecules reside in the structure of the individual pockets in the antigenic-peptide-binding groove. H-2Kb, which has a deep C pocket, binds specifically peptides with a tyrosine or a phenylalanine at position 5. In contrast, HLA-A2 has a shallow C pocket, which cannot accommodate large side chains at position 5. Site-directed mutagenesis was used to generate a chimera between the murine H-2Kb and the human HLA-A2 [H-2Kb/HLA-A2(C')]. The structure of this chimera is similar to H-2Kb except for the region around the deep C pocket, where residues at positions 9, 97 and 99 were substituted with those bulkier residues from HLA-A2. Peptide binding between this chimera and H-2Kb-binding peptides [VSV (52-59), OVA (257-264), and MCMV pp89 (168-176)], revealed that the deep C pocket of H-2Kb was crucial for high-affinity binding. While a peptide, VSV (52-59), was found to bind with severalfold lower 'affinity' to H-2Kb/HLA-A2(C') than to the wild-type H-2Kb, a VSV analogue with the tyrosine in position 5 (Tyr5) substituted with an alanine was found to bind with a similar 'affinity' to both MHC class I molecules. Computer-aided modelling of the H-2Kb/HLA-A2(C') complex indicates that the VSV (52-59) peptide probably binds to the chimeric MHC molecule with the peptide side chain of anchor residue Tyr5 pointing away from the groove. These results confirm a role of the individual pockets in determining peptide-binding affinity and specificity and suggest that this may be accomplished by changes in side-chain orientation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9583994     DOI: 10.1046/j.1365-3083.1997.d01-102.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  9 in total

1.  Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove.

Authors:  Lori J Silveira; Erin C McCanlies; Tasha E Fingerlin; Michael V Van Dyke; Margaret M Mroz; Matthew Strand; Andrew P Fontenot; Natalie Bowerman; Dana M Dabelea; Christine R Schuler; Ainsley Weston; Lisa A Maier
Journal:  J Immunol       Date:  2012-09-12       Impact factor: 5.422

2.  An In Vivo Screen to Identify Short Peptide Mimotopes with Enhanced Antitumor Immunogenicity.

Authors:  Xuedan He; Shiqi Zhou; Breandan Quinn; Dushyant Jahagirdar; Joaquin Ortega; Mark D Long; Scott I Abrams; Jonathan F Lovell
Journal:  Cancer Immunol Res       Date:  2022-03-01       Impact factor: 12.020

3.  Different strategies adopted by K(b) and L(d) to generate T cell specificity directed against their respective bound peptides.

Authors:  Natalie A Bowerman; Leremy A Colf; K Christopher Garcia; David M Kranz
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

4.  The Carboxy Terminus of the Ligand Peptide Determines the Stability of the MHC Class I Molecule H-2Kb: A Combined Molecular Dynamics and Experimental Study.

Authors:  Esam Tolba Abualrous; Sunil Kumar Saini; Venkat Raman Ramnarayan; Florin Tudor Ilca; Martin Zacharias; Sebastian Springer
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

5.  Critical assessment of approaches for molecular docking to elucidate associations of HLA alleles with adverse drug reactions.

Authors:  Kerry A Ramsbottom; Daniel F Carr; Andrew R Jones; Daniel J Rigden
Journal:  Mol Immunol       Date:  2018-08-18       Impact factor: 4.407

6.  Informatics investigations into anti-thyroid drug induced agranulocytosis associated with multiple HLA-B alleles.

Authors:  Kerry A Ramsbottom; Daniel F Carr; Daniel J Rigden; Andrew R Jones
Journal:  PLoS One       Date:  2020-02-06       Impact factor: 3.240

7.  Charge-based interactions through peptide position 4 drive diversity of antigen presentation by human leukocyte antigen class I molecules.

Authors:  Kyle R Jackson; Dinler A Antunes; Amjad H Talukder; Ariana R Maleki; Kano Amagai; Avery Salmon; Arjun S Katailiha; Yulun Chiu; Romanos Fasoulis; Maurício Menegatti Rigo; Jayvee R Abella; Brenda D Melendez; Fenge Li; Yimo Sun; Heather M Sonnemann; Vladislav Belousov; Felix Frenkel; Sune Justesen; Aman Makaju; Yang Liu; David Horn; Daniel Lopez-Ferrer; Andreas F Huhmer; Patrick Hwu; Jason Roszik; David Hawke; Lydia E Kavraki; Gregory Lizée
Journal:  PNAS Nexus       Date:  2022-07-27

8.  Rapid peptide exchange on MHC class I by small molecules elucidates dynamics of bound peptide.

Authors:  Andries Hadeler; Ankur Saikia; Martin Zacharias; Sebastian Springer
Journal:  Curr Res Immunol       Date:  2022-08-18

9.  Chemical Modification of Influenza CD8+ T-Cell Epitopes Enhances Their Immunogenicity Regardless of Immunodominance.

Authors:  Sietske K Rosendahl Huber; Jolien J Luimstra; Josine van Beek; Rieuwert Hoppes; Ronald H J Jacobi; Marion Hendriks; Kim Kapteijn; Casper Ouwerkerk; Boris Rodenko; Huib Ovaa; Jørgen de Jonge
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.